TrkB receptor-agonizing mAbs (Wyeth)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTrkB receptor-agonizing mAbs (Wyeth)
Drug Alias Nametyrosine kinase receptor B receptor-agonizing mAbs (Pfizer)tyrosine kinase receptor B receptor-agonizing mAbs (Wyeth)29D7
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 2 stimulants
TargetsNeurotrophic tyrosine kinase receptor type 2
Therapy Area/IndicationsEye DiseasesCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Research
Active IndicationsN/A
Inactive IndicationsEye DiseasesCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A